Hybrid Blood Pressure Monitor Validation (NISSEI)
Primary Purpose
Essential Hypertension
Status
Completed
Phase
Phase 4
Locations
Greece
Study Type
Interventional
Intervention
Blood Pressure Measurement
Sponsored by
About this trial
This is an interventional diagnostic trial for Essential Hypertension focused on measuring Blood pressure measuring devices, Essential Hypertension, Automated blood pressure measurement
Eligibility Criteria
Inclusion Criteria:
- Above 25 years of age
- Sinus rhythm
- Informed consent
Exclusion Criteria:
- Sustained arrhythmia
- Pregnancy
- Poor quality Korotkoff sounds
- Unavailable cuff size
- Completed blood pressure range (according to protocol)
Sites / Locations
- Hypertension Center, Third Department of Medicine, University of Athens, Greece
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
All patients
Arm Description
All eligible patients in the study consist a single group and the same intervention is assigned to all of them.
Outcomes
Primary Outcome Measures
Systolic Blood Pressure Measured by Tested Device.
Mean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Systolic Blood Pressure Measured With Mercury Sphygmomanometer.
Mean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Diastolic Blood Pressure Measured by Tested Device.
Mean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.
Mean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01120990
Brief Title
Hybrid Blood Pressure Monitor Validation
Acronym
NISSEI
Official Title
Validation of a Hybrid Blood Pressure Monitor to Replace the Mercury Standard for Validation Studies According to Modified Criteria of the European Society of Hypertension International Protocol 2010
Study Type
Interventional
2. Study Status
Record Verification Date
April 2012
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
July 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Athens
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Assessment of the accuracy of a Blood Pressure Measuring Device with a digital display-column, NISSEI DM 3000, according to an adaptation of the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults".
Detailed Description
According to the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults", 33 patients have their blood pressure measured by two observers using parallel connected mercury sphygmomanometers, blinded from each other's result, and then by the supervisor using the tested device, NISSEI DM 3000. The measurements using the mercury sphygmomanometers are repeated 5 times and in between them, 4 measurements using the tested device take place. If the results of the comparison of these measurements according to the analysis required by the protocol, meet the required criteria, the device is regarded as "Pass", otherwise as "Fail".
In this study, instead of consecutive, simultaneous measurements of the two mercury sphygmomanometers and tha tested device will be taking place. This will be so to exclude any inaccuracy due to blood pressure variability and because the tested device has a controllable deflation rate and allows simultaneous measurements with the mercury sphygmomanometers. In addition, the investigators will be performing 6 set of measurements instead of 4.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Essential Hypertension
Keywords
Blood pressure measuring devices, Essential Hypertension, Automated blood pressure measurement
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
51 (Actual)
8. Arms, Groups, and Interventions
Arm Title
All patients
Arm Type
Other
Arm Description
All eligible patients in the study consist a single group and the same intervention is assigned to all of them.
Intervention Type
Other
Intervention Name(s)
Blood Pressure Measurement
Intervention Description
All patients have their blood pressure measured simultaneously by two observers using parallel connected mercury sphygmomanometers and by a supervisor using the tested device, NISSEI DM 3000. Six sets of measurements are performed.
Primary Outcome Measure Information:
Title
Systolic Blood Pressure Measured by Tested Device.
Description
Mean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Time Frame
3 months
Title
Systolic Blood Pressure Measured With Mercury Sphygmomanometer.
Description
Mean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Time Frame
3 months
Title
Diastolic Blood Pressure Measured by Tested Device.
Description
Mean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Time Frame
3 months
Title
Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.
Description
Mean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Above 25 years of age
Sinus rhythm
Informed consent
Exclusion Criteria:
Sustained arrhythmia
Pregnancy
Poor quality Korotkoff sounds
Unavailable cuff size
Completed blood pressure range (according to protocol)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
George S Stergiou, MD
Organizational Affiliation
Hypertension Center, Third Depertment of Medicine, University of Athens, Greece
Official's Role
Study Chair
Facility Information:
Facility Name
Hypertension Center, Third Department of Medicine, University of Athens, Greece
City
Athens
Country
Greece
12. IPD Sharing Statement
Learn more about this trial
Hybrid Blood Pressure Monitor Validation
We'll reach out to this number within 24 hrs